Panacea Biotec: Manjula Upadhyay ceases to be Independent Director, Chairperson/member of Committees of Board of Directors
Advertisement
New Delhi: Panacea Biotec Limited has announced that Manjula Upadhyay, Independent Director of the Company, has completed her second and final term of five consecutive years as Independent Director on March 29, 2025 and consequently she has ceased to be the director of the Company.
Accordingly, she has also ceased to be the Chairperson/member of the Committees of the Board of Directors of the Company. Manjula Upadhyay will however continue to be non-executive independent director of the Company’s material wholly-owned subsidiary company, Panacea Biotec Pharma Limited.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.